Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
Other Operating Expenses
Glenmark Life Sciences Ltd
Other Operating Expenses Peer Comparison
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Other Operating Expenses
-₹3.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-95%
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Other Operating Expenses
-₹63.5B
|
CAGR 3-Years
-152%
|
CAGR 5-Years
-67%
|
CAGR 10-Years
-9%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Other Operating Expenses
-₹148.8B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-14%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Other Operating Expenses
-₹46.9B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Other Operating Expenses
-₹26.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-9%
|
See Also
What is Glenmark Life Sciences Ltd's Other Operating Expenses?
Other Operating Expenses
-3.5B
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Other Operating Expenses amounts to -3.5B INR.
What is Glenmark Life Sciences Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
-95%
Over the last year, the Other Operating Expenses growth was -1 273%.